Bettina Höhlich

Title: Bettina Höhlich: Innovator in Immunogenic Peptides

Introduction

Bettina Höhlich is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of immunology, particularly in the development of vaccines for foot-and-mouth disease. Her innovative work has garnered attention in the scientific community and has implications for animal health.

Latest Patents

Bettina Höhlich holds a patent for "Immunogenic peptides of foot-and-mouth disease viruses." This invention relates to a vaccine based on peptides that have a sequence of at least 8 amino acids. These peptides correspond to a partial sequence of the non-structural protein region of the foot-and-mouth disease virus (FMDV). The selection of these peptides was based on their immunoreactivity with FMDV-specific antibodies or T lymphocytes. The patent outlines their production and use, highlighting the potential for improved vaccine efficacy.

Career Highlights

Bettina has been associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. Her work at Bayer has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in vaccine development.

Collaborations

Some of her notable coworkers include Roberto Correa and Hans-Robert Hehnen. Their collaborative efforts have further advanced the research and development of immunogenic peptides, enhancing the understanding of foot-and-mouth disease.

Conclusion

Bettina Höhlich's contributions to the field of immunology through her innovative patents and collaborations underscore her role as a key figure in vaccine research. Her work not only addresses critical health issues but also paves the way for future advancements in immunogenic therapies.